Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0PU6F
|
|||
Former ID |
DNC005880
|
|||
Drug Name |
2-(1H-benzo[d]imidazol-2-yl)quinoxaline
|
|||
Synonyms |
CHEMBL200636; benzimidazolylquinoxaline; benzimidazole-quinoxaline, C1; BDBM21215; 2-(1H-benzimidazol-2-yl)quinoxaline; 2-(1H-Benzoimidazole-2-yl)quinoxaline
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H10N4
|
|||
Canonical SMILES |
C1=CC=C2C(=C1)NC(=N2)C3=NC4=CC=CC=C4N=C3
|
|||
InChI |
1S/C15H10N4/c1-2-6-11-10(5-1)16-9-14(17-11)15-18-12-7-3-4-8-13(12)19-15/h1-9H,(H,18,19)
|
|||
InChIKey |
AYFBMQMYJRNGIM-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Derivatives of 4-amino-6-hydroxy-2-mercaptopyrimidine as novel, potent, and selective A3 adenosine receptor antagonists. J Med Chem. 2008 Mar 27;51(6):1764-70. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.